ST Pharm

237690, KOSDAQ, Healthcare

₩96,400▼ ₩504-0.52%2026-10-07 close

Prev. close: ₩96,904
Volume: 90.8K
Market cap: ₩2T

Near 52-week low
-44% from high

Stock and sector context

Healthcareoutflow

Sector comparison: ST Pharm changed -0.52%. The 13 covered Healthcare stocks in Korean averaged -0.82%, with estimated sector flow of outflow.
Variables to watch: Drug approvals and trial resultsDrug pricing policyUS interest ratesUSD/KRW
Risks to check: -44% below the high, the downtrend may continue
Clinical trial failure
Drug pricing pressure

This compares price changes among covered stocks in the same market. It does not establish why prices moved. Variables and risks are sector reference lists.

Why a candidate

Match 54/100

The match score marks how many conditions overlap on a 0 to 100 scale: the 52-week range, valuation metrics, price change and volume. It is not a probability of rising or a forecast return.

vs 52w high -44%Oversold

Today's read

ST Pharm scores 54 out of 100 on today's InverseOne match ranking, 21 of 60 in the Korean large-cap universe. The gap to its 52-week high is 79%. Today's move of -0.52% came with money flowing out; the broader Healthcare sector flow is worth checking. Scores are estimates built from price and volume, a starting point for research rather than a trading signal.

Data basis: 2026-10-07 close, 10-12 00:16 KST updated, For reference only, not advice

Same-sector stocks, Healthcare

Lending balance

Unwinding

903,913 sh

KRW 0.08T

1D -1.23%5D +3.88%

New 81 sh, Returned 11,350 sh

Shares borrowed through securities lending that have not yet been returned. Borrowed shares are often sold afterwards, so the balance is used as a reference for pending sell pressure.

As of 2026-10-08, FSC stock lending data

Talk about this stock

New thread

Today's talking points

It sits low in its 52-week range (14).
Borrowed shares are coming back. The lending balance is shrinking.
It is 79% below its 52-week high.

Three months out, which way do you see it?

Nobody has answered yet. Sign in to be the first.

These are answers picked by members, not investment advice.

Fund-flow signal

Outflow index-₩45.5M

Net flow, Outflow

Market flow rank: Outflow #42 of 45
Sector flow rank: #7 of 13

Trend building (not enough trading days)

Market data

52-week range: ₩84,100 ~ ₩172,100

52-week position14/100

₩84,100₩172,100

Gap to 52w high+78.5%

AI zone read

Worth watchingCondition score 68

Evidence

Near the low14
Gap to the high78.5

No headline was judged for this stock, so only price measures were used.

This formula has not passed after-the-fact validation yet. Its results are being collected on the record page.

AI reads the headlines; the zone comes from a published formula.

See the formula

Same-sector stocks

LigaChem Biosciences141080, Healthcare-4.05%HLB028300, Healthcare-3.16%Samsung Biologics207940, Healthcare-2.52%CLASSYS214150, Healthcare-2.07%HK inno.N195940, Healthcare-1.33%Hugel145020, Healthcare+1.16%ALTEOGEN196170, Healthcare-1.15%Celltrion Pharm068760, Healthcare+1.13%

These figures are reference estimates built from price and volume: a starting point for narrowing down ideas, not a buy or sell signal.